Misappropriation of 11th Five Year Plan Funds at NIPER is likely to exceed Rs.100 crores - Part I

           Large scale financial misappropriation of about Rs. 100 crores (Rs. One Hundred Crores) of 11th  Five Year Plan (2007-2012) funds,  released to NIPER for carrying out research projects but used for non-approved purposes the truth will be disclosed in a three part here.

      Final presentations of the projects held on 18^th April, 2012 at NIPER, Mohali were just an eyewash:  

Approved Schemes under 11^th Five Year Plan:

Ongoing  - 22 (Rs.95 crores outlay)

New - 19 (Rs.61.89 crores outlay)

Final presentations:

Ongoing - 14 out of 22  (Rs.64.14 crores outlay; Progress of ongoing schemes, total outlay of Rs.30.86 crores, not presented)

New - 3 only out of 19 (Rs.19.68 crores outlay; Progress of new schemes total outlay of Rs. 42.21 crores not presented)

Thus, during presentations,  progress of ongoing and new schemes having total outlay of Rs.73.07 crore (Rs.30.86 + Rs.42.21 crores ), was not presented at all.

Details of the schemes for which final report was presented, are given below:

S. No.	Name of the scheme/Code	Presentation by	Scheme Code/Outlay
Continuing Schemes (Final report of only 14 out of 22 presented)
1.	Pharma grid	Dr P.V. Bharatam	C-07 Rs.11.06 crores
2.	Pharmaco-informatics	Dr P.V. Bharatam	C-08 Rs.03.25 crores
3.	Pharma Parasitology/ virology/ Infection laboratory	Dr P.P. Singh	C-05 Rs.09.13 crores
4.	Nanotechnology & drug delivery systems	Dr Neeraj Kumar	C-11 Rs.05.25 crores
5.	In-vitro/Alternative method of screening	Dr K.B. Tikoo	C-03 Rs.04.75 crores
6.	Advanced centre for traditional medicines	Dr Sanjay M. Jachak	C-14 Rs.06.39 crores
7.	Standardization of herbal products	Dr I.P. Singh	C-16 Rs.02.23 crores
8.	Diabetes complications	Dr S.S. Sharma	C-04 Rs.05.50 crores
9.	Pharmacological and Toxicological Screening Facilities	Dr S.S. Sharma	C-17 Rs.01.48 crores
10.	Lead molecules for TB, Malaria and Leishmania	Dr A.K. Chakraborti	C-06 Rs.05.15 crores
11.	Chiral drugs/ bio-chemo enzymatic-transformation	Dr U.C. Banerjee	C-09 Rs.01.78 crores
12.	Reference standard development	Dr Saranjit Singh	C-13 Rs.02.00 crores
13.	Impurity profiling facility	Dr Saranjit Singh	C-15 Rs.01.02 crores
14.	Clinical research Training	Dr Pramil Tiwari	C-06 Rs.05.15 crores
		Total	Rs. 64.14 crores
New Schemes (Final report of only 3 out of 19 presented)
15.	Drugs for most neglected diseases	Dr K.P.R. Kartha	N-18 Rs.15.83 crores
16.	New specialization in Pharm. Management	Dr Anand Sharma	N-14 Rs.01.60 crores
17.	Intellectual Property Right	Dr P.Bansal	N-17 Rs.02.25 crores
		Total	Rs. 19.68 crores
	Total		Rs.83.82 crores